Tuesday, June 14, 2005

 

Intervexion and Medicago ink a deal

Intervexion will be relying on Medicago to supply them with quantities of their PCP addiction-beating antibody for clinical studies. Looks like Intervexion doesn't want to commit capital at this time for manufacturing. Probably not a bad move. Question is, what plant will be used as the expression host? Link to Yahoo's write-up
# posted by Brian @ 6/14/2005 11:42:00 AM
|


<< Home





This page is powered by Blogger. Isn't yours?